Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Mezigdomide (MEZI) monotherapy in relapsed/ refractory multiple myeloma (RRMM): results from the CC-92480-MM-001 trial

Scott Goldsmith,Albert Oriol,Pekka Anttila,Nizar Bahlis,Jesus Berdeja,Andrew Cowan,Meletios Dimopoulos,Laahn Foster,Jens Hillengass,Martha Louzada,Ka Lung Wu,Tracy Chow,Wencong Chen,Yue Wang,Alessia Spirli,Phillip Koo,Paulo Maciag,Daniel Zhu,Jessica Katz,Paul Richardson

Clinical Lymphoma, Myeloma & Leukemia（2023）

Cited 0|Views11
No score
Key words
refractory multiple myeloma,multiple myeloma,rrmm,mezigdomide
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined